Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$552.68 -5.28 (-0.95%)
As of: Sep 4, 2026 · 11:51 AM EDT

Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2017)

Analysis

Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn -
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn
10 Incyte 25.60 Bn 21.07 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 22.14%
Sep 30, 2017 28.84%
Jun 30, 2017 40.96%
Mar 31, 2017 -71.94%
Dec 31, 2016 25.41%
Sep 30, 2016 0.42%
Jun 30, 2016 0.23%
Mar 31, 2016 0.22%
Dec 31, 2015 0.11%
Sep 30, 2015 0.01%
Jun 30, 2015 0.01%
Mar 31, 2015 0.01%
Dec 31, 2014 0.01%
Mar 31, 2011 31.29%
Dec 31, 2010 374.36%
Sep 30, 2010 -72.33%